HRT and Weight Loss: What Bioidentical HRT Can and Can't Do for the Scale

Does HRT help with weight loss? What the trials actually show

Not as a weight-loss tool. In the large trials, women on hormones did not lose weight compared with women on a placebo, a dummy pill. At best, hormone therapy slightly slowed the gain that tends to come with menopause.

The Menopause Society, the leading US group of menopause clinicians and researchers, weighed this evidence in its 2022 hormone therapy position statement. Its conclusion is short. Hormone therapy may help limit belly fat buildup and weight gain around menopause, but the effect is small.

The other key studies point the same way.

• The Cochrane review: a Cochrane review pools every good trial on one question. This one pooled 28 randomized trials, where chance decides who gets the drug. It found no evidence that estrogen, alone or with a progestogen, changes body weight or prevents the weight gain usual at menopause. A progestogen is the second hormone, given to protect the lining of the uterus.
• The WHI: the Women's Health Initiative is the largest US hormone therapy trial. The Menopause Society notes that weight gain over its first 3 years did not differ significantly between hormones and placebo. Waists grew a little less on hormones.
• PEPI: in this 3-year US trial, women on estrogen gained about 2 pounds less than women on placebo. Their waists grew about half an inch less. That waist gap faded once the smaller weight gain was taken into account.
• Belly fat and blood sugar: a meta-analysis is a study that pools the results of many trials. One meta-analysis of 107 trials found hormone therapy reduced abdominal fat and insulin resistance. Insulin resistance means the body responds poorly to insulin, the hormone that clears sugar from the blood. It also found fewer new cases of diabetes in women who did not have it.

That diabetes finding is real. Still, The Menopause Society points out that hormone therapy is not approved to prevent diabetes.

Muscle is where marketing runs furthest ahead of the evidence. A WHI substudy of 835 women used DXA scans, a low-dose X-ray that measures fat and muscle separately. Over 3 years, women on hormones lost less lean tissue, which is mostly muscle. The authors called the effect small.

The Menopause Society adds that this early edge did not stop the slow muscle loss of aging. It also notes that systematic reviews found hormone therapy neither helped nor harmed muscle mass. Strength training and protein remain the real muscle plan.

If your worry runs the other way, that HRT made you gain, the trials say no. Our guide to whether hormone therapy causes weight gain walks through that evidence.

Is bioidentical HRT better for weight loss?

No. Bioidentical means a hormone built exactly like the one your ovaries made. The word covers two very different kinds of product, and neither has been shown to cause weight loss.

• FDA-approved bioidentical hormones: estradiol patches, gels, sprays and pills, plus micronized progesterone capsules. They are tested, regulated and sold with full prescribing information. The big weight trials above mostly tested an older estrogen called conjugated estrogens, so there is no reason to expect more weight effect from estradiol.
• Compounded bioidentical hormones: mixed by a pharmacy for one patient and not FDA-approved. They come as creams, capsules, troches, which are lozenges, and pellets placed under the skin. They often combine several hormones, such as estriol and testosterone.

Compounding clinics often sell these plans with promises about metabolism, energy and weight. The evidence does not back those promises.

A 2020 report from the National Academies of Sciences, Engineering, and Medicine found insufficient evidence that compounded bioidentical hormones are clinically useful. It said marketing claims of better safety and benefits were not backed by well-designed studies.

The FDA says it has no evidence that compounded bioidentical hormones are safer or more effective than approved hormone therapy. In 2008, it sent warning letters to seven pharmacies over false and misleading claims about these products. The agency called "bio-identical" a marketing term without a medical or scientific basis.

The Menopause Society lists its own concerns about compounded hormones: minimal regulation, overdosing and underdosing, impurities and missing safety data. It calls the saliva and urine hormone tests often sold with these plans unreliable for setting doses.

Approved products are also the ones the FDA is relabeling. In February 2026, it removed the heart, breast cancer and dementia warnings from the boxed warning on a first group of six HRT products. Compounded hormones carry no FDA label at all.

What about testosterone and pellets?

Testosterone often turns up in pellet plans sold for energy, libido or weight. No testosterone product is FDA-approved for women in the US. The 2019 Global Consensus Position Statement on testosterone for women names only one evidence-based use: low sexual desire that causes real distress after menopause.

That statement recommends against compounded testosterone. It also cautions against pellets and injections, which tend to push levels above the normal female range.

For costs and how these programs work, see our pages on compounded HRT and HRT pellets. Our guide to the best HRT for menopause compares the approved forms.

What is the best HRT for weight loss? There isn't one

No hormone product is approved for weight loss, so no form wins on that score. A 2026 clinical review in Obesity Pillars, the journal of the Obesity Medicine Association, says HRT should not be marketed or prescribed for weight loss.

If weight is on your mind as you choose a form, three points are worth knowing.

• Skin or pill: estrogen through the skin, from a patch, gel or spray, skips a first pass through the liver. Pills tend to raise triglycerides, a type of blood fat, more than skin forms do. That matters for metabolic health more than for the scale.
• The progestogen: in the PEPI trial, weight change did not differ between the hormone combinations tested, including one with micronized progesterone. Bloating is a separate issue, and it is water, not fat.
• Thinking ahead to a GLP-1: GLP-1 weight drugs slow how fast pills leave the stomach. A skin form of estrogen sidesteps that question for estrogen. Progesterone capsules are still swallowed, and no study has measured the effect for HRT.

For bloating on hormones and how a change of progestogen can help, see does hormone therapy cause weight gain. The best HRT for menopause guide covers which form suits which profile.

How HRT can help with weight indirectly

The real weight benefit of hormone therapy often comes through a side door. It treats the symptoms that make healthy habits hard to keep.

• Sleep: The Menopause Society says hormone therapy improves sleep in women with bothersome night sweats by cutting night waking. It also notes that poor sleep has been linked to obesity and metabolic syndrome, a cluster of blood sugar, blood pressure and waist problems.
• Hot flashes: hormone therapy remains the most effective treatment for them. Fewer flashes can make a workout, or simply a long day, easier to get through.
• Energy to change habits: the Mayo Clinic team behind a 2026 tirzepatide study suggested that symptom relief may make diet and exercise changes easier to keep. That is an idea to test, not a proven effect.

The link also runs the other way. The Menopause Society's 2023 nonhormone position statement lists weight loss among the recommended ways to ease hot flashes, based on limited evidence. That same statement does not recommend exercise, yoga or diet changes as hot flash treatments.

For why the middle changes in the first place, see perimenopause belly fat and the broader perimenopause weight gain guide.

Will I lose weight if I stop HRT?

Probably not, and no study shows that stopping leads to fat loss. Trials find hormone therapy does not add fat, so there is no fat to give back.

Water is another story. The Menopause Society lists bloating and fluid retention among the more common side effects of hormone therapy. If those bothered you, some puffiness may ease after you stop. That is water leaving, not fat.

The small brake on belly fat seems to fade instead. OsteoLaus was a Swiss cross-sectional study, meaning it scanned each woman only once. It included just over 1,000 women after menopause.

Current hormone users had less deep belly fat than women who had never used hormones. Past users, including those who stopped early, showed no lasting benefit. The authors urged caution when hormone therapy is stopped.

A snapshot like this compares different women at one moment. It cannot prove that stopping causes gain. It does suggest the belly-fat effect lasts only while you take hormones.

Hot flashes are the more predictable change. The Menopause Society says they return in about half of women who stop. If night sweats come back, broken sleep can follow, and the indirect help described above goes with it.

On how to stop, The Menopause Society says there is no consensus on whether stopping at once or tapering the dose is better. It also says hormone therapy does not need to be stopped routinely at 60 or 65.

Can you take HRT and a GLP-1 together?

Yes, and many women do. GLP-1 drugs such as semaglutide, sold as Wegovy, and tirzepatide, sold as Zepbound, mimic gut hormones that curb appetite. Neither label lists HRT as an interaction.

Both labels warn that these drugs slow stomach emptying, which can change how pills are absorbed. A 2026 review in Maturitas found no study measuring this for the progestogens used in HRT. It calls lower absorption on tirzepatide plausible but unproven, with any risk highest when starting or raising the dose.

Our GLP-1 in perimenopause guide covers how the two mix in more detail.

Does HRT make a GLP-1 work better?

Possibly, but the evidence is early. Two US studies looked back at the medical records of women already taking both. Researchers call this a retrospective design.

• Semaglutide: a 2024 study in the journal Menopause followed 106 postmenopausal women on semaglutide. Only 16 of them used hormone therapy. At one year, hormone users had lost about 16% of their weight, against about 12% for non-users.
• Tirzepatide: a Mayo Clinic study of 120 postmenopausal women on tirzepatide was published in 2026. Women also on hormone therapy lost more weight than women on tirzepatide alone. It was not a randomized trial, so it cannot show that hormones caused the difference.

Women who choose hormone therapy may differ in other ways, such as habits or access to care. The Obesity Pillars review calls these findings limited by small samples, retrospective design and confounding, meaning other factors could explain them. A 2026 Spanish Menopause Society statement adds that the link should not justify starting HRT just to boost weight loss.

Menopause itself does not seem to blunt these drugs. In a post hoc analysis of the SURMOUNT trials, postmenopausal women on the highest tolerated dose of tirzepatide lost about 23% of their weight, against about 3% on placebo. Post hoc means the groups were sorted after the trial ended. That analysis did not look at HRT.

One claim to skip is that HRT protects your muscle while you are on a GLP-1. No study has shown it. Our guide to GLP-1 muscle loss in perimenopause covers what does help.

If you still have periods

The studies above enrolled women after menopause. If you still have periods, pregnancy is possible, and HRT doses are not birth control.

The Zepbound label advises women on the birth control pill to switch to a non-oral method, or add a barrier method such as condoms. That applies for 4 weeks after starting and after each dose increase. The label for Foundayo, the daily GLP-1 pill, gives the same advice for 30 days.

When a weight medication makes more sense, and who qualifies

If losing weight is the goal, a medicine built for weight loss is the right tool. The gap with hormone therapy is large.

• Semaglutide, sold as Wegovy: in the STEP 1 trial, adults on the drug lost about 15% of their weight on average, against about 2% on placebo. The trial ran 68 weeks.
• Tirzepatide, sold as Zepbound: in SURMOUNT-1, adults on the top dose lost about 21% of their weight, against about 3% on placebo. That trial ran 72 weeks.

Hormone therapy trials, by contrast, show differences of a pound or two at most.

Both drugs are FDA-approved for adults with obesity, or with overweight plus at least one weight-related condition such as high blood pressure. In their trials, obesity meant a body mass index, or BMI, of 30 or more. Overweight meant a BMI of 27 or more.

GLP-1s are not the only option. Our weight loss medication plan for perimenopause lays out the full sequence, older pills included. For a side-by-side of the two approaches, read HRT vs. Ozempic for perimenopause weight gain.

Our guide to GLP-1s for menopause weight gain covers how they work at this stage. The menopause weight loss programs comparison shows what each program includes.

HRT or a GLP-1 first? A sensible plan by profile

There is no official order. The right first step depends on what bothers you most.

• Hot flashes and broken sleep are the main problem: treat the symptoms with HRT first. Add protein and strength training for the weight, then reassess after a few months.
• Weight is the main goal and symptoms are mild: a weight medication, if you qualify, does the job HRT cannot. You do not need hormones to take one.
• Both are real problems: the two can run side by side. A skin form of estrogen takes estrogen out of the pill absorption question, though oral progesterone stays in it.
• You cannot take hormones: nonhormone hot flash treatments exist. Losing weight may itself ease hot flashes.
• You still have periods: plan birth control first, because pregnancy is possible and tirzepatide can make the pill less reliable.

Whatever the order, the daily habits stay the same. The perimenopause weight gain diet guide covers protein and meals. Weight-bearing exercise in perimenopause covers the training side.

When weight change deserves a closer look

Midlife weight gain is common, but a few patterns point to something other than menopause.

• Fast gain, or new swelling in your legs, ankles or face: The Menopause Society lists fluid retention among hormone therapy side effects. Swelling can also have other causes worth checking.
• Gain with tiredness, feeling cold, dry skin or thinning hair: the NIH lists these among signs of an underactive thyroid. A simple blood test can check for it.

Our guide to what causes perimenopause weight gain covers these other causes in detail.